Workflow
Lawsuit risk
icon
Search documents
Canaccord Genuity's Anderson: Kenvue sell-off ‘unwarranted,' stock looks like a buying opportunity
Youtube· 2025-09-22 17:30
Welcome back to Money Movers. Take a look at Tylenol maker Ken View. Down over 7% at record lows now following reports that the Trump administration is planning to link Tylenol to autism risk during pregnancy.A Ken View spokesperson telling CNBC in part, quote, "We believe independent sound science clearly shows that taking acetamophen does not cause autism." President Trump is scheduled to make remarks on quote significant medical and scientific findings for America's children at 400 pm Eastern time today. ...